SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high...read more
Category - M&As and partnerships
PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
Multiple targeted assays from Pillar Biosciences to be combined with the PierianDx platform to reduce time, cost, and complexity of clinical genomic testing St. LOUIS, MO. and NATICK, MA., OCTOBER 14, 2020 —PierianDx...read more
10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions
Signs Agreement to Acquire ReadCoor; Acquires Sweden’s CartaNA AB PLEASANTON, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) — Continuing on its mission of mastering biology to advance human health, 10x...read more
Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes Adds Multi-Disciplinary Team and Capabilities Harnessing...read more
